Background
During a crisis and especially a public health emergency of international concern (PHEIC), 1,2 communications, clarity and connection with the public, scientists, physicians and clinicians is of utmost importance. The information shared needs to be succinct, accurate and tailored for the audience. 3 Frequently, information on the outbreak or topic du jour provided by the US Federal international agencies are densely populated with scientific words. Thus, one solution for sharing complex information is presenting visual abstracts, infographics with pictures.
Objective
We evaluated the information provided by generative artificial intelligence (AI) models to develop visuals and infographics on the current Ebola PHEIC declared on 17 May 2026, by the World Health Organization (WHO). 4 The objective was to determine the accuracy of the information provided in the end output of visual representation of the current known outbreak of the Ebola species Bundibugyo virus, to the prior outbreaks of the species of Zaire virus.
Methods
The free tiers of Microsoft Copilot 5 and Google Gemini 6 were used to generate comparative visual graphics on the two different known outbreaks by the Budibugyo and the Zaire species during two different sessions in late May 2026 to early June 2026.
Using Microsoft Copilot: On May 21st 2026, Microsoft Copilot was given a prompt to develop the infographic. The websites with scientific information provided by the US Centers for Diseases Control and Prevention (CDC) and WHO were put within the prompt (Figure 1). This prompt was general as noted in Figure 1 and stated “develop infographic comparing the Ebola Zaire with Bundibugyo, use the CDC websites,” with website links provided.
Initial prompt on May 21st 2026.

Microsoft Copilot verified the information received and furthermore, indicated its goal of only using accurate information (Figure 2).
Response to the initial prompt, from Microsoft Copilot.

One of the coauthors had previously used this AI model to develop infographics related to infectious diseases, and with a previous interaction with this AI model, had requested assessment of the carbon footprint with generation of infographic. The estimation of the carbon footprint was not in the prompt; Microsoft Copilot opted to voluntarily report on this metric (Figure 3) stating “you previously requested carbon footprint transparency. I will include estimated CO 2 equivalent for generating the infographic; miles driven equivalent (per your prior format).” The importance of estimation or impact of the carbon footprint is not discussed as it was beyond the scope of this study.
Response from AI model on prior request on carbon footprint generated by AI.

Further interactions of the AI model with the human (coauthor) is shown below (Figure 4). Although the human response was brief, this specific AI model provided a lengthy response. And of note, the retention of prior interactions of the human is seen by the response of the AI model, even indicating the known scientific conferences for infectious diseases.
Response and suggestion from AI model to develop poster for known scientific conferences of infections diseases.

The AI provided further choices and the prompt subsequently given by human (coauthor) at this juncture was “generate full visual poster mockup” as noted in Figure 5.
Further responses from AI and prompt provided by human.

Use of AI models on a different date: In early June 2026, as the Ebola outbreak continued, further interactions with generative AI models were explored. A more specific prompt was used with Microsoft Copilot. However, although the AI provided texts and suggestions, it did not generate any visual infographics, stating the maximum limit was reached by the user (for the free tier).
Thus, another AI model (Google Gemini) was assessed to determine feasibility of developing community facing posters as well as infographics. The following specific prompt was provided along with the prior websites:
Generate a community-facing poster about the two species of ebola the zaire and bundibugyo based on these websites. Do not use any copyrighted phrases, nor icons, nor photos, nor pictograms https://www.cdc.gov/han/php/notices/han00530.html
A follow up prompt tailored for healthcare personnel was also provided with the aforementioned websites:
“Generate an infographic for healthcare personnel about the two species of ebola the zaire and bundibugyo based on these websites. Do not use any copyrighted phrases, nor icons, nor photos, nor pictograms”
and within a minute the infographic was generated by the Gemini AI model.
Of note, the difference in the prompts and AI models used, at different time periods, generated different visuals and infographics.
Results
Using Microsoft Copilot
Interaction in end of May: Over an initial period of 30 to 45 minutes the human (coauthor) interacted with the AI model providing the initial general prompt (“Develop infographic comparing the Ebola Zaire with Bundibugyo, using the websites links provided”). Revisions of this prompt were required with each output, with the human needing to respond to different options suggested as a solution by the AI model. Microsoft Copilot provided a visual abstract as shown in Figure 6. The AI visual output did provide an easy to understand visual comparison. It generated the similarities and differences on multiple points between these two species, in the domains of prior historical outbreaks, clinical, diagnostics, treatment and prevention.
The first visual information shown with the errors including the CDC level 3 travel notice should have been under the column of Ebola Bundibugyo (generated May 21st 2026).

Figure 6. Long description
The table compares Ebola Zaire and Ebola Bundibugyo virus species across various categories. It has two columns: Ebola Zaire and Ebola Bundibugyo, and ten rows: Virus Species, Case Fatality Rate, Major Outbreaks, Incubation Period, Symptoms, Transmission, Diagnosis, Treatment, Vaccine, Prevention, and Travel Notice. Row 1: Virus Species, Zaire ebolavirus, Bundibugyo ebolavirus. Row 2: Case Fatality Rate, 60-90 percent, 25-35 percent. Row 3: Major Outbreaks, DRC, West Africa 2014-16, Uganda 2007-2008, DRC 2012. Row 4: Incubation Period, 2-21 Days, 2-21 Days. Row 5: Symptoms, Fever, Vomiting, Hemorrhage, Fever, Vomiting, Rash. Row 6: Transmission, Blood, Body Fluids, Contaminated Objects, Handshake, Blood, Body Fluids, Contaminated Objects, Handshake. Row 7: Diagnosis, R T-PCR, Antigen Tests, R T-PCR, Antigen Tests. Row 8: Treatment, Inmazeb, Ebanga, Supportive Care. Row 9: Vaccine, r V S V-Z E B O V (Ervebo), No Approved Vaccine. Row 10: Prevention, Personal Protective Equipment, Hand Hygiene, Safe Burial Practices, Personal Protective Equipment, Hand Hygiene, Safe Burial Practices. Row 11: Travel Notice, C D C Level 3: D R C Outbreaks.
Subsequently, based on the multiple choices provided by the AI model to the coauthor led to another visual presentation (Figure 7). Of note, although initial assessment of the output can be impressive, upon closer review, it is noted that the output had spelling errors (“Epidomiologic”—instead of “Epidemiology”). Other misalignment of the visual representation includes the icon showing healthcare exposure did not truly represent the required personal protective equipment for healthcare personnel, nor provide explanation of the icons listed as “body fluids,” unsafe burials and healthcare exposure as the possible routes of exposure and thus risks of infection. Another major point of concern was that the visual infographic generated by the model highlights there - was genetic divergence between the two species of Zaire and Bundibugyo, however the percent divergence noted (55%–60%) was inaccurate.
Visual representation generated by AI model (May 21st 2026).

As shown in Figure 8 the output generated by the AI model (21 May 2026) was in a poster format for a conference, with a hypothetical name (confabulated name, and university).
Poster format output generated by AI model.

Figure 8. Long description
Panel A: Virology & Epidemiology. The Zaire and Bundibugyo species show approximately 55-60 percent genome divergence. The case fatality rate for Zaire is 60-90 percent, while for Bundibugyo it is 25-35 percent. Transmission occurs through body fluids, funerals, healthcare settings, and community spread. Panel B: Clinical Course & Treatment. The clinical course is divided into dry and wet phases. The dry phase includes fever and fatigue, while the wet phase includes vomiting and diarrhea. Both phases can lead to leukopenia, thrombocytopenia, and elevated AST/ALT levels. Treatment options include Inmazeb & Banga and supportive care. Panel C: Outbreak Timeline & Geography. The timeline shows Zaire outbreaks from 1976 to 2022 and Bundibugyo outbreaks from 2007 to 2026. The map highlights outbreak locations in the Democratic Republic of the Congo (D R C) and Uganda.
Subsequently another session was initiated on the same day at the end of May. And a new prompt was provided to Microsoft Copilot including confirmation by the human to the AI for a community facing poster. As the prior websites were included, the AI output generated (Figure 9) information including the CDC logo. It also had the spelling error of “heading” instead of “headache.”
Community facing poster generated by AI model in end of May 2026.

With the prompt “delete the words of CDC WHO Ministry of health and the CDC Logo” the AI output generated a revised poster (Figure 10), with also the correct spelling of headache.
Community facing poster, without the logos, and spelling that AI self corrected.

Figure 10. Long description
Panel A: Description of Ebola. Ebola is a severe virus found in parts of Africa, with strains Zaire (Severe) and Bundibugyo (Milder). It does not spread through air. Symptoms include fever, weakness, vomiting, diarrhea, headache, muscle pain, and bleeding or bruising. Panel B: Symptoms and early care. Symptoms include fever, weakness, vomiting, diarrhea, headache, muscle pain, and bleeding or bruising. Seek medical help if feeling sick after travel. Panel C: How Ebola spreads. It spreads through body fluids, contaminated items, caring for sick, and funeral contact. It does not spread by air, food, or water. Panel D: Prevention and response. Wash hands often, avoid sick people, practice safe burials, undergo travel screening, and report symptoms.
The AI output was assessed on June 2nd, 2026 with a more specific prompt with the Microsoft Copilot. Although the AI model resulted in many rounds of text communications, the AI model declined to generate visuals indicating that the user (coauthor) had reached the limit for generating visuals.
Below are the results from the Gemini model from early June 2026 for the community facing poster (Figure 11). Although this output was generated within a minute and did not have spelling errors, the visual output provided lots of information that may have been overwhelming for some of the audiences. This AI model also developed visuals showing people with dark skin color, which may limit its use to certain audiences only.
Different AI model output for community facing poster (on June 2nd 2026).

Results of the prompt for generating infographic specifically for healthcare personnel using the Gemini model are shown in Figure 12.
Infographic for healthcare personnel generated by AI model (on June 2nd 2026).

Figure 12. Long description
Infographic comparing Zaire Ebolavirus and Bundibugyo Ebolavirus. Panel A: Species Overview. Zaire Ebolavirus (EBOV) has caused most major outbreaks with significant virulence and pathogenesis. Bundibugyo Ebolavirus (BDBV) has less frequent outbreaks and is generally considered less severe. Core symptoms for both include fever, myalgia, vomiting, and diarrhea. Panel B: Clinical Distinctions. Observed differences include higher fatality rates, higher peak viral loads, and more reported neurological impairment for EBOV compared to BDBV. Panel C: Infection Prevention and Control. Strict adherence to PPE protocols is required for all Ebola virus disease suspect cases. Diagnostic considerations include high sensitivity and specificity with common assays for EBOV and may require specific PCR primers or assays for BDBV. Panel D: Global Outbreak Context. Major Zaire outbreaks occurred in the Democratic Republic of the Congo and Uganda, with recent Bundibugyo outbreaks identified in the same regions.
Limitations
Generative AI has a variety of limitations. The figures shown of the initial prompts and outputs generated primarily demonstrate the limitations associated with prompt writing, and the results generated with vague as well as more specific prompts. Other limitations include model/tool choice and tier choice. For example, Microsoft Copilot is not a highly rated tool for image generation compared to other tools such as Google Gemini. Furthermore, even within a single tool such as Google Gemini, the model choice (eg, fast vs thinking) will significantly impact the accuracy of the image generated. Finally, many features are locked behind different payment tiers; the figures above demonstrate Microsoft Copilot’s free tier. Higher payments may yield different models due to access to more recent (and likely more intelligent) model options. Users also need to factor the rapidly evolving nature of AI models and the limited generalizability of infographics, especially with any new scientific developments leading to changes in generated output.
Discussions
Although the clinician needs to be aware of the aforementioned limitations, there are also advantages of using generative AI to assist with developing communication infographics. Using generative AI can assist with communicating complex information in simple visual formats. Time spent on designing visuals can also be decreased with the use of generative AI. Especially as outbreaks unfold, and there is change in outbreak numbers and information received, and scientific studies published, developing more timely visuals, in simple formats, can assist with public health messaging.
Conclusion
Clinicians can leverage existing generative AI models to assist with developing infographics and other visuals for educational purposes. These models can be used to assist contextualize the information for the intended audience. However, clinicians need to also know the limitations of these models, as well as providing specific prompts. As these models get further trained by the interactions of multiple users, the output generated may be unique. Ultimately, although clinicians may adopt and use generative AI, it is wise to verify the visual output for both scientific accuracy as well as content representation. This work does not include formal assessment of usability, readability, user satisfaction or communication effectiveness. Further assessments are needed to understand implications of widescale adoption of generative AI for communications on infections and public health risks.
Author contributions
Manuscript conceptualization: TAM, DJW
Methods and results: TAM, KB, DJW
Manuscript writing and editing: TAM, KB, DJW
Financial support
No funding received for work and developing this manuscript.
Competing interests
KB and DJW do not have any conflicts of interest to report. TAM reported individual stocks in Alphabet Inc. and GE Healthcare Tech Inc.
